Screening at-risk patients can reduce lung cancer mortality by 20%. Immunotherapy such as with checkpoint inhibitors has also shown promise in improving outcomes for some patients with late-stage disease.
After initial treatments produced no effect, repeat nivolumab therapy results in a decrease in hilar adenopathy and a reduction of symptoms for a patient with stage IIIA adenocarcinoma.Continue reading
Septic shock cases are rare but deadly. New resources and guidelines tested in a research collaboration have helped speed diagnosis and care delivery and reduce mortality rates.Continue reading
The number of patients awaiting transplant continues to far exceed available donor organs. In hopes of expanding access, a new initiative re-evaluates the use of a subset of deceased-donor kidneys.Continue reading